Newstral
Article
Reuters on 2018-10-30 11:29
AstraZeneca verkauft Arzneimittelrechte an Grünenthal
Related news
- Grünenthal übernimmt Rechte an AstraZeneca-CholesterinsenkerReuters
- FAstraZenecaft.com
- MBrit Boris Johnson receives an AstraZeneca vaccinemvtelegraph.com
- Linde-Fusionspartner Praxair verkauft Europageschäft an JapanerReuters
- VAstraZeneca vaccine recipients can get another AstraZeneca vaccine or an mRNA vaccinevoiceonline.com
- Here’s how an AstraZeneca spinout deal gets donebizjournals.com
- GDid Biden and Mexico Barter an Exchange for AstraZeneca Vaccines?Guardian Liberty Voice
- How an iPod Shuffle explains the AstraZeneca blood clot storySydney Morning Herald
- AstraZeneca gets an additional FDA approval for its diabetes drugbizjournals.com
- European Stock Favorites From AstraZeneca To VodaphoneForbes
- FAstraZeneca secures Acerta Pharma stakeft.com
- AstraZeneca buys respiratory drug businessThe Toledo Blade
- AstraZeneca says could begin COVID-19 vaccine production early in 2021amny.com
- ‘Completely incorrect’: AstraZeneca denies report vaccine less effective in elderlySydney Morning Herald
- HU.K. Rolls Out AstraZeneca Vaccine, Touts First Starter Statushamodia.com
- HAstraZeneca to Buy Alexion for $39B to Expand in Immunologyhamodia.com
- HEU Preparing Legal Case Against AstraZeneca Over Vaccine Shortfallshamodia.com
- AstraZeneca asks the F.D.A. to authorize an antibody treatment to prevent Covid-19.The New York Times
- BAstraZeneca Stock Gets an Upgrade from Morgan Stanley. Why It’s a Buy.barrons.com
- IAstraZeneca says its COVID-19 vaccine has an efficacy of 70% on averageinvezz.com